US Patent 7312356 Medicament
Patent 7312356 was granted and assigned to Cyclacel Limited on December, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Jan Sarek0
John R. Ferguson0
Jonathan D. Hull0
Paul M. Blaney0
Peter Martin Fischer0
Piers Collier0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+184 characters)
Article
Patent abstract
The present invention relates to 3β,28-diacetoxy-18-oxo-19,20,21,29,30-pentanorlupan-22-oic acid methanol solvate, its use in medicine and processes for its preparation.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07312356 Medicament US Patent 7312356 Medicament
Infobox
Patent Number
07312356
Patent Number
7312356
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07312356 Medicament
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07312356
Date of patent
December 25, 2007
Patent application number
10846217
Date Filed
May 14, 2004
Patent primary examiner
Find more entities like US Patent 7312356 Medicament
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
